Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-08-29

Clinical Trial Update: Efficacy of Topical Azelaic Acid 15% Gel Plus Anti-inflammatory Dose Doxycycline or Metronidazole Gel 1% Plus Anti-inflammatory Dose Doxycycline in Moderate Papulopustular Rosacea [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating topical azelaic acid 15% gel combined with anti-inflammatory doxycycline versus metronidazole 1% gel with anti-inflammatory doxycycline…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azelaic acid 15% gel (azelaic acid)
  • Doxycycline (anti-inflammatory dose) (doxycycline)
  • Doxycycline (anti-inflammatory dose) with metronidazole combination (doxycycline)
  • Metronidazole gel 1% (metronidazole)

Snippet

Sponsor: LEO Pharma | Conditions: Papulopustular Rosacea | Phase 4 | Status: COMPLETED | Results posted: 2012-08-29